Excellent supplier Glasgow Epigenetics Lab 2025-11-23Verified Purchase High-quality compound with proper documentation
If youre battling obesity or need aggressive appetite suppression due to metabolic disorders, medications like Semaglutide, or Liraglutide may offer faster results
not FDA-approved, and studies did not confirm a clear weight-loss benefit
Diagnosed with phaeochromocytoma
Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
The Lipo part usually refers to lipotropic compounds that could help the body metabolize fat